Paper Details

  1. Home
  2. Paper Details

Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Author: BryantAndrew, GaitskellKezia, HaldarKrishnayan, KehoeSean, MorrisonJo, NicumShibani

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Ovarian cancer is a significant cause of death in women worldwide. While initial treatment with surgery and platinum-based chemotherapy can be effective, about 55% to 75% of patients experience a relapse within two years. Second-line treatment is palliative, aiming to manage symptoms and prolong life. New drugs targeting the epidermal growth factor receptor (EGFR) are being developed for advanced ovarian cancer, and their effectiveness and safety need to be evaluated.
Paper Details　
Original Abstract of the Article :
Ovarian cancer is the seventh most common cause of cancer death in women world-wide. Treatment consists of a combination of surgical debulking and platinum-based chemotherapy, alone or in combination with paclitaxel. Between 55% and 75% of women who respond to first-line therapy relapse within two y...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD007927.pub3

データ提供：米国国立医学図書館（NLM）

Targeting the Epidermal Growth Factor Receptor (EGFR) in Ovarian Cancer

The authors explore the challenging world of ovarian cancer, a disease that affects women worldwide. Imagine a vast desert landscape, where a hidden oasis holds the key to survival. This research seeks to uncover the secrets of this hidden oasis, exploring new approaches to treating ovarian cancer.

The study focuses on epidermal growth factor receptor (EGFR) blockers, a new class of drugs that target a key growth factor involved in tumor development. Think of EGFR as a gatekeeper to a bustling marketplace, controlling the flow of essential resources for tumor growth. By blocking EGFR, these drugs aim to disrupt the supply chain, effectively starving the tumor.

A New Weapon in the Fight Against Cancer

This research highlights the potential of EGFR blockers as a novel treatment for ovarian cancer. These drugs offer a promising new avenue for combatting this challenging disease, potentially extending the lives of patients and improving their quality of life. It is like discovering a new weapon in the desert, giving warriors the edge they need to overcome their enemy.

Hope for the Future

This research underscores the need for continued research into new and innovative treatments for ovarian cancer. By unraveling the mysteries of this disease and developing targeted therapies, we can strive to create a brighter future for women facing this diagnosis. Just as a desert can bloom after a rare rainfall, so too can we hope to see a blossoming of progress in the treatment of ovarian cancer.

Dr.Camel's Conclusion

This research presents compelling evidence for the potential of EGFR blockers in the fight against ovarian cancer. It is a testament to the dedication of researchers in developing new and innovative treatments for this challenging disease. While more research is needed, this work offers a glimmer of hope for those seeking better treatments for ovarian cancer.

Date :
  1. Date Completed 2011-11-02
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

21975775

DOI: Digital Object Identifier

10.1002/14651858.CD007927.pub3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.